
Medoxyprogesterone | CAS:520-85-4
Medoxyprogesterone
- 名称:甲羟孕酮 | Medoxyprogesterone
- CAS号:520-85-4
- 别名:6alpha-Methyl-17alpha-hydroxypregn-4-ene-3,20-dione; NSC 27408; U 8840
- 分子式:C22H32O3
- 分子量:344.49
- EINESC号:208-298-6
产品描述
物理化学性质
熔点 | 220-223.5 ºC** |
---|---|
密度 | 1.13±0.1 g/cm3 (20 ºC |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Determination of atmospheric isocyanate concentrations by high-performance thin-layer chromatography using 1-(2-pyridyl) piperazine reagent. Ellwood PA, et al. Analyst, 106(1258), 85-93 (1981)
Absorption and fluorescence of 1-(2-pyridyl)-piperazine and four diisocyanate derivatives in solution. Salthammer T, et al. Journal of Photochemistry and Photobiology A: Chemistry, 107(1), 159-164 (1997)
6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats.Harvey Wong et al.Drug metabolism and disposition: the biological fate of chemicals, 35(8), 1387-1392 (2007-05-15)
New lithocholic and chenodeoxycholic piperazinylcarboxamides with antiproliferative and pro-apoptotic effects on human cancer cell lines.Laïla El Kihel et al.Bioorganic & medicinal chemistry, 16(18), 8737-8744 (2008-09-05)
Pharmacological evidence for the involvement of 1-(2-pyridinyl)-piperazine (1-PmP) in the interaction of buspirone or gepirone with noradrenergic systems.P Giral et al.European journal of pharmacology, 134(1), 113-116 (1987-01-28)
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.Robert Lavieri et al.Bioorganic & medicinal chemistry letters, 19(8), 2240-2243 (2009-03-21)
Determination of trace atmospheric isocyanate concentrations by reversed-phase high-performance liquid chromatography using 1-(2-pyridyl) piperazine reagent. Goldberg PA, et al. Journal of Chromatography A, 212(1), 93-104 (1981)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!